What happened to the JOHNSON & JOHNSON VACCINE?Modern and Pfizer. In recent months we only hear about these two vaccines anti-coronavirus. But who happened to be the viral carrier serum of Johnson & Johnson? To understand this we must take a step back.
In mid-July, as also reported by the Huffingtonpost newspaper, the regions had asked the commissioner to suspend deliveries, due to low use, both for Johnson & Johnson, both for AstraZeneca. Non-use prolonged over time in fact risked bringing entire batches of vaccine to expiration. And so it happened. In short, the single-dose vaccine that it seemed like a small revolution in the fight against the COVID-19 pandemic, it suddenly almost disappeared from the radar due to inactivity. Many vials remained in the refrigerators, others have already expired: here is what happened to the drug produced by the US company.
Ma there are news. As also reported by the authoritative New York Times, Johnson & Johnson ha presentato alla Food and Drug Administration, US drug agency, the request for authorization for a booster of your COVID vaccine in subjects aged 18 or over.
The company said the booster given 56 days after the first dose provides 94% protection against symptomatic disease et al 100% against serious illness, starting 14 days after the recall.
About this Marco Cavaleri, responsible for vaccines and therapeutic products for COVID of the European Medicines Agency (Ema), said: “We are in contact with Johnson & Johnson to understand when there will be a clinical data package that can support one potential clearance of a second dose Also in Italy of its single-dose vaccine. Data from a large study on safety and efficacy of the two doses, but with an interval of 2 months from each other “.